American Association for Cancer Research: Response to Adjuvant Bevacizumab Among Patients With Resected Melanoma May Vary By Age

Press/Media

PeriodOct 24 2020

Media coverage

1

Media coverage

  • TitleAmerican Association for Cancer Research: Response to Adjuvant Bevacizumab Among Patients With Resected Melanoma May Vary By Age
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date10/24/20
    PersonsMitchell Fane
View all 1
View less